$1.40
0.053.7%
Last update: Nov 12, 4:22 PM
Chemomab Therapeutics Ltd (CMMB) Stock Price, Quote, News & History
CMMBNASDAQ
Chemomab's OLE study of nebokitug in PSC patients confirmed safety and showed improvements in liver stiffness, fibrosis biomarkers, and cholestasis markers.
You can purchase shares of Chemomab Therapeutics (NASDAQ:CMMB) through any online brokerage.
Other companies in Chemomab Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Chemomab Therapeutics has a consensus price target of $27.00.
The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $1.4 last updated November 12, 2026 at 4:22 PM EST.
There are no upcoming dividends for Chemomab Therapeutics.
Chemomab Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Chemomab Therapeutics.
Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
